Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.

BA.1 Omicron disease burden sub-lineage vaccine

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 01 06 2023
accepted: 02 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fimmu.2023.1130539.].

Identifiants

DOI: 10.3389/fimmu.2023.1232965 PMID: 37377964 PMC: PMC10292686
pubmed: 37377964
doi: 10.3389/fimmu.2023.1232965
pmc: PMC10292686
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1232965

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Pather, Madhi, Cowling, Moss, Kamil, Ciesek, Muik and Türeci.

Auteurs

Shanti Pather (S)

BioNTech, Mainz, Germany.

Shabir A Madhi (SA)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Benjamin J Cowling (BJ)

School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Paul Moss (P)

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.

Jeremy P Kamil (JP)

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United States.

Sandra Ciesek (S)

Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.

Alexander Muik (A)

BioNTech, Mainz, Germany.

Özlem Türeci (Ö)

BioNTech, Mainz, Germany.

Classifications MeSH